What are the key drivers and resistors for development of diagnostics and therapeutics in rare diseases?
How to build a value proposition and sustainable business plan in this setting?
When moving outside R&D, which additional challenges arise?
How to design clinical trials and establish strategic partnerships?
Which efforts can be undertaken to ensure access and affordability of orphan drugs?
Faculty Club, Groot Begijnhof 14, 3000 Leuven, Belgium
Junior academic: € 295
Senior academic: € 420
Industry and other: € 550
Registration includes: access bootcamp, catering during the event and networking reception on Monday 4 November 2019
FLANDERS.BIO MEMBER BENEFIT: flanders.bio members receive a 15% discount. Please contact us to receive a code you can use during registration.